Form 4: Castle Biosciences Director Olson Exercises Stock Options
SEC Form 4 Filing
Director Tiffany Olson exercised stock options to acquire 487 shares of Castle Biosciences (CSTL) common stock on May 10, 2024.
Summary
- On May 10, 2024, Tiffany Olson, a director of Castle Biosciences, exercised stock options.
- This transaction involved the acquisition of 487 shares of common stock.
- Following the transaction, Olson directly owns 7,767 shares of Castle Biosciences common stock.
- The options were related to Restricted Stock Units (RSUs) granted on May 10, 2021, which vest in three equal annual installments beginning May 10, 2022.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock option exercises, indicating a neutral sentiment.
Industry Context
This is a routine disclosure related to insider transactions, common for publicly traded companies. It provides transparency into the trading activities of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/10/2021 | Reporting Person was granted 1,460 RSUs, which vest in three equal annual installments beginning on May 10, 2022. |
| 05/10/2022 | First vesting date of RSUs granted on May 10, 2021. |
| 05/10/2024 | Date of transaction: Olson exercised stock options to acquire 487 shares of common stock. |
| 05/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.